Mulay James's Form 4 filing
CG Oncology, Inc. (CGON) · filed Sep 8, 2025
- Accession no.
- 0000950170-25-113556
- Filed
- Sep 8, 2025
- Trade date
- Sep 5, 2025
- Filing delay
- 3 days
- Rule 10b5-1 plan
- Checked
This filing lists 5 non-derivative transactions and 1 derivative transaction. Open-market sales total $851.8K. It was filed 3 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Mulay JamesCIK 0001684531 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Common Stock | MOption exerciseAcquired | +27,015 | $0.60 | +$16,209 | 27,015 | Direct | |
| Sep 5, 2025 | Common Stock | SSaleDisposed | −12,342 | $30.47 | −$376,060.74 | 14,673 | Direct | |
| Sep 5, 2025 | Common Stock | SSaleDisposed | −4,095 | $31.42 | −$128,664.9 | 10,578 | Direct | |
| Sep 5, 2025 | Common Stock | SSaleDisposed | −7,465 | $32.64 | −$243,657.6 | 3,113 | Direct | |
| Sep 5, 2025 | Common Stock | SSaleDisposed | −3,113 | $33.22 | −$103,413.86 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Sep 5, 2025 | Common Stock | MOption exerciseDisposed | −27,015 | $0.00 | $0 | 0 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.